title: Melanocytic activation in HIV-1 disease: HMB-45 staining in common acquired nevi. Military Medical Consortium for the Advancement of Retroviral Research.
abstract: BACKGROUND
  An increase in pigmented lesions has been reported in HIV-1-infected patients. In a study of HIV-1-positive patients, we have seen patients who noticed new or changing pigmented lesions.
  
  
  OBJECTIVE
  The goal of this study was to determine to what degree these pigmented lesions showed evidence of significant melanocytic proliferation as opposed to increased pigment production without significant melanocytic proliferation.
  
  
  METHODS
  Biopsy specimens were studied with routine light microscopy and immunohistochemical stains including S-100 protein, HMB-45, and proliferating cell nuclear antigen.
  
  
  RESULTS
  The lesions included two malignant melanomas and 42 benign melanocytic lesions. Significant staining of dermal melanocytes with HMB-45 was present in two of three melanomas and in 19 of 42 nevi. With stains for proliferating cell nuclear antigen there was a positive reaction in the dermal component of both melanomas and a negative reaction in the dermal cells of the nevi.
  
  
  CONCLUSIONS
  In some HIV-1-infected patients there is stimulation of melanosome production without significant melanocyte proliferation.
authors.affiliation: Department of Dermatology, National Naval Medical Center, Bethesda.
authors.forename: K J
authors.initials: KJ
authors.lastname: Smith
authors.forename: H G
authors.initials: HG
authors.lastname: Skelton
authors.forename: W
authors.initials: W
authors.lastname: Heimer
authors.forename: D
authors.initials: D
authors.lastname: Baxter
authors.forename: P
authors.initials: P
authors.lastname: Angritt
authors.forename: D
authors.initials: D
authors.lastname: Frisman
authors.forename: K F
authors.initials: KF
authors.lastname: Wagner
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D001706:Biopsy; D002280:Basal Cell Carcinoma / Q000150:complications* / Q000473:pathology; D002455:Cell Division; D004416:Dysplastic Nevus Syndrome / Q000150:complications / Q000473:pathology; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000382:microbiology / Q000473:pathology; D015497:HIV-1; D006801:Humans; D008297:Male; D008544:Melanocytes / Q000473:pathology; D008545:Melanoma / Q000150:complications* / Q000473:pathology; D009506:Nevus / Q000150:complications* / Q000473:pathology; D018330:Nevus, Intradermal / Q000150:complications / Q000473:pathology; D009687:Nuclear Proteins; D018809:Proliferating Cell Nuclear Antigen; D009418:S100 Proteins; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000150:complications* / Q000473:pathology; D013194:Staining and Labeling
chemical_list: D000911:Antibodies, Monoclonal; D000951:Antigens, Neoplasm; D009687:Nuclear Proteins; D018809:Proliferating Cell Nuclear Antigen; D009418:S100 Proteins